Immune Design Corp. (NASDAQ:IMDZ)’s Basic Consolidated EPS Came In At $-2.0591

0

The annual basic consolidated EPS for Immune Design Corp. (NASDAQ:IMDZ) posted annual basic consolidated EPS of $-2.0591 for the year period ended2015-12-31. But basic consolidated EPS for the quarter period ended 2015-12-31 came in at $-2.0591.

What About EPS from continuing operations

Immune Design Corp. (NASDAQ:IMDZ)’s EPS from continuing operations for the annual period ended 2015-12-31 came in at -2.0591. On quarterly basis, EPS from continuing operations stood at $-2.0591 for the three-month period ended 2015-12-31.

EPS contribution from parent

Immune Design Corp. (NASDAQ:IMDZ) received of $-2.0591 EPS boost from the parent company for the annual period ended 2015-12-31. For the quarter period ended 2015-12-31, the company received EPS boost of $-2.0591 from its parent company.

What About Basic net EPS

The company’s basic net EPS for the annual period ended 2015-12-31 was$-2.06, but for the quarter period ended 2015-12-31 the basic net EPS was $-2.06.

What About Consolidated Diluted EPS?

Immune Design Corp. (NASDAQ:IMDZ) posted consolidated diluted EPS of $-2.0591 for the annual period ended 2015-12-31. On the other hand, consolidated diluted EPS for the quarterly period ended 2015-12-31 stood at $-2.0591.

Basic diluted EPS

The company’s diluted EPS from continuing operation stood at $-2.0591 for the annual period ended 2015-12-31. On quarter basis, diluted EPS from continuing operations was $-2.0591 for the three-month period ended 2015-12-31.

Net diluted EPS

Immune Design Corp. (NASDAQ:IMDZ) posted net diluted EPS of $-2.06for the annual period ended 2015-12-31. On the other hand, it posted net diluted EPS of $-2.06 for thequarterly period ended 2015-12-31.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of Immune Design Corp. (NASDAQ:IMDZ) contributed diluted EPS of $-2.0591. The diluted EPS contribution from the parent for the quarter ended 2015-12-31 stood at $-2.0591.

The company’s net basic EPS for the annual period ended 2015-12-31 was $-2.06 while for the quarter period ended 2015-12-31 it was $-2.06.

Immune Design Corp. (NASDAQ:IMDZ) had average basic shares outstanding of 19.156 for the annual period ended 2015-12-31 and 19.156 for the quarter period ended 2015-12-31.The number of diluted shares outstanding was 19.156 for the annual period ended 2015-12-31 and 19.156 for the quarter ended 2015-12-31.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 12 times, 1 visits today)